基于专利分析的天然抗肿瘤药制剂技术发展态势研究

发布时间：2018-10-21 12:14

【摘要】：目的:基于专利文献深入分析天然抗肿瘤药制剂技术的发展态势。方法:采用专利计量分析、统计学趋势分析等定量分析方法结合药学专业知识的定性分析方法从专利申请数量、国家/地区分布、专利技术领域等方面对天然抗肿瘤药制剂技术领域的发展态势进行分析。结果:天然抗肿瘤药制剂技术专利年申请数量在3000件左右,处于比较稳定平稳的发展时期;专利申请主要集中在美国和中国;专利技术领域主要集中在抗肿瘤活性和剂型的相关研究。结论:美国专利申请数量排名第一,远远领先于其他国家,且专利质量很高,处于绝对的领先地位。中国虽然在专利申请数量方面具有一定优势,但是专利质量亟待提高,与国外发达国家相比仍有较大差距。
[Abstract]:Objective: to analyze the development trend of natural anti-tumor drug technology based on patent literature. Methods: patent quantitative analysis, statistical trend analysis and qualitative analysis of pharmaceutical professional knowledge were used to analyze the number of patent applications and the distribution of countries / regions. The development trend of natural anti-tumor agents was analyzed in patent technology field. Results: the number of patent applications for natural antineoplastic agents was about 3000, which was stable and stable, and the patent applications were mainly in the United States and China. Patent technology mainly focuses on the study of anti-tumor activity and dosage form. Conclusion: the United States ranks first in the number of patent applications, far ahead of other countries, and patent quality is very high, in absolute leading position. Although China has some advantages in the number of patent applications, the quality of patents needs to be improved, and there is still a big gap compared with developed countries.
【作者单位】：中国医学科学院/北京协和医学院医学信息研究所/图书馆;
【基金】：北京协和医学院协和青年基金和中央高校基本科研业务费专项(3332013151) 中国医学科学院医学信息研究所中央级公益性科研院所基本科研费项目(12R0113) 中国医学科学院/北京协和医学院药物研究所天然药物活性物质与功能国家重点实验室开放课题(GTZK201508)
【分类号】：R943;G306

【相似文献】